Combination therapy using P53 activator and c-Met inhibitor
Abstract:
A method of preventing and/or treating a cancer comprising co-administering a p53 activator and a c-Met inhibitor to a patient in need thereof.
Public/Granted literature
Information query
Patent Agency Ranking
0/0